Xiumin Wang | Infectious Diseases Prevention, Control and Cure | Innovative Research Award

Innovative Research Award

Xiumin Wang
Institute of Feed Research, Chinese Academy of Agricultural Sciences

Xiumin Wang
Affiliation Institute of Feed Research, Chinese Academy of Agricultural Sciences
Country China
Scopus ID 36971321100
Documents 113
Citations 2,788
h-index 30
Subject Area Infectious Diseases Prevention, Control and Cure
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-2008-856X

The Innovative Research Award recognizes distinguished scientific achievements that contribute to the advancement of infectious disease prevention, control, and therapeutic development. Xiumin Wang has established a notable academic profile through sustained research activities, publication output, and interdisciplinary investigations within animal health, microbial sciences, feed safety, and infectious disease management. The researcher’s scholarly contributions have supported scientific understanding of pathogen interactions, host responses, and evidence-based disease mitigation strategies within agricultural and public health contexts.[1]

Abstract

Xiumin Wang has developed an extensive body of research addressing infectious disease prevention, microbial ecology, animal nutrition, feed safety, and host–pathogen interactions. Through interdisciplinary investigations, the researcher has contributed to understanding mechanisms that influence disease transmission, immune responses, and biological control strategies in agricultural systems. Scholarly publications demonstrate consistent engagement with topics relevant to microbial management and health optimization. Supported by a substantial publication record, citation performance, and international visibility, Wang’s research has enhanced scientific knowledge while contributing practical insights for disease mitigation, sustainable production systems, and evidence-based approaches supporting infectious disease control and prevention initiatives worldwide.[1][2]

Keywords

Infectious Diseases, Disease Prevention, Feed Safety, Microbial Ecology, Host–Pathogen Interaction, Animal Health, Immunology, Antimicrobial Research, Agricultural Biosciences, Disease Control.

Introduction

The prevention and control of infectious diseases require collaborative research efforts spanning microbiology, immunology, epidemiology, and agricultural sciences. Scientific advances in these areas support improved understanding of disease dynamics and facilitate the development of innovative intervention strategies. Xiumin Wang’s research portfolio reflects this interdisciplinary perspective, integrating biological and applied sciences to address challenges associated with pathogen management, animal productivity, and public health protection.[2]

Research Profile

Affiliated with the Institute of Feed Research at the Chinese Academy of Agricultural Sciences, Xiumin Wang has established a research profile characterized by significant scholarly productivity and sustained scientific influence. The researcher’s Scopus-indexed publication record includes more than one hundred documents and a citation count approaching three thousand, demonstrating broad engagement with topics relevant to infectious diseases, microbial regulation, nutrition-associated immunity, and disease prevention technologies. The achieved h-index further reflects the consistency and impact of these scientific contributions.[1]

Research Contributions

Wang’s research contributions have focused on advancing knowledge regarding microbial communities, feed-associated biological interventions, pathogen control mechanisms, and host immune regulation. These investigations have generated evidence supporting improved health management practices while expanding scientific understanding of interactions between nutrition, microbiota, and disease susceptibility. The resulting findings have contributed to ongoing efforts aimed at reducing disease risks and promoting sustainable approaches to infectious disease prevention within animal production systems.[3][4]

Publications

The publication portfolio of Xiumin Wang encompasses peer-reviewed journal articles addressing microbial biotechnology, feed-derived bioactive compounds, pathogen resistance, animal health, and infectious disease management. Research outputs have appeared in internationally recognized scientific journals and have attracted considerable scholarly attention. Several studies have explored biological alternatives to conventional disease-control measures, reflecting contemporary priorities in antimicrobial stewardship and sustainable health interventions.[3]

Research Impact

The measurable impact of Wang’s scholarship is reflected through citation performance, research visibility, and continued relevance within scientific literature. Contributions have informed subsequent investigations examining microbial regulation, disease prevention, and health optimization strategies. By connecting fundamental biological research with practical applications, the work has supported knowledge transfer across academic, veterinary, agricultural, and public health disciplines, thereby strengthening broader efforts toward effective infectious disease control.[1][4]

Award Suitability

Xiumin Wang demonstrates strong alignment with the objectives of the International Research Awards on Infectious Diseases. The researcher’s established publication record, substantial citation impact, interdisciplinary expertise, and contributions to disease prevention science collectively support consideration for recognition under the Innovative Research Award category. The combination of scientific productivity and practical relevance illustrates a sustained commitment to advancing research that contributes to improved disease management and health outcomes.[1][5]

Conclusion

The academic achievements of Xiumin Wang reflect a sustained and impactful contribution to infectious disease-related research. Through extensive publication activity, influential scientific findings, and interdisciplinary collaboration, the researcher has strengthened understanding of disease prevention and biological health management. These accomplishments support recognition within international research award frameworks dedicated to innovation, scientific excellence, and meaningful advancement of infectious disease research.

References

  1. Elsevier. (n.d.). Scopus author details: Xiumin Wang, Author ID 36971321100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36971321100
  2. ORCID. (n.d.). Xiumin Wang Research Profile.
    https://orcid.org/0000-0002-2008-856X
  3. Microorganisms. (2025). Anti-Inflammatory and Antidiarrheal Effects of Two Strains of Lactic Acid Bacteria Isolated from Healthy Pets on Escherichia coli K88-Induced Diarrhea in Mice.
    https://doi.org/10.3390/microorganisms13020239
  4. Zhenlong Wang, ,Xiumin Wang, Jianhua Wang. (2018). Recent Advances in Antibacterial and Antiendotoxic Peptides or Proteins from Marine Resources.
    https://doi.org/10.3390/md16020057
  5. International Research Awards on Infectious Diseases. (2026). Award Information and Recognition Framework.
    https://infectious-diseases-conferences.pencis.com/

Dr.Yuanyuan Qiao | Pathogen Evolution and Adaptation | Research Excellence Award

Dr.Yuanyuan Qiao | Pathogen Evolution and Adaptation | Research Excellence Award

Vice professor | Binzhou medical university | China

Dr. Yuanyuan Qiao is an accomplished researcher recognized for contributions to virology and immunological studies, particularly in viral pathogenesis and antibody-based analysis, with a strong record of impactful scientific publications . With extensive professional experience in academic and laboratory research environments, Dr. Qiao has demonstrated expertise in advancing knowledge in infectious diseases and immune response mechanisms. Research interests include viral immunology, neutralizing antibodies, and infectious disease control, supported by strong skills in molecular biology, data analysis, and experimental design. Recognized through scholarly achievements and collaborative research contributions, Dr. Qiao continues to advance scientific innovation and global health research. She has achieved 114 Citations, 10 Documents, 6 h-index.

 

 

Citation Metrics (Scopus)

120
60
0

114
Citations

10
Documents

6
h-index

Citations

Documents

h-index


View Google Scholar Profile

View Scopus Profile

Featured Publications

Nominee | Subject Area | Award Category

Your Nomination Has Been Selected

Congratulations. Your nomination has been officially approved and selected.
Award profile publication, certification, and verification services
are enabled only after successful registration.

Important: This page is published for registration purposes only.
Public announcement and verification services will be activated after registration.

Free Services Included

  • Nomination acknowledgement
  • Expert review process
  • Published award winners announcement list –

    View list
  • A dedicated nominee details page for verification purposes –

    Sample page

Registration Benefits (Select as You Wish)

  • Profile publication –

    Sample
  • Certification and verification services –

    Sample
  • Printed certificate by post
  • Printed momento by post
  • Online e-certificate download (any time)
  • QR-code verified certificate linked to a public verification page
  • Media posts publication
  • Winners promotional video publication
  • Award event celebrations
  • Global award indexing

Digital credentials are typically available within 2–3 working days after registration.
Printed certificates and mementos are dispatched within
30–45 days via secure international air post.

Xin Su | Infectious Diseases | Best Researcher Award

Dr. Xin Su | Infectious Diseases | Best Researcher Award

Attending Physician | Nanjing University | China

Professor Xin Su, M.D., Ph.D., is a distinguished clinical scientist and Chief Physician renowned for his pioneering contributions to respiratory and critical care medicine, with particular expertise in the study and management of severe pulmonary infections. Over a distinguished career spanning nearly three decades, he has demonstrated an exceptional ability to bridge clinical excellence with translational research innovation. His work focuses on the pathogenesis, diagnosis, and treatment of invasive pulmonary aspergillosis (IPA) in non-neutropenic patients, a challenging and underexplored domain of pulmonary medicine. As a leading investigator, Professor Su has spearheaded multicenter studies that have transformed the understanding of pulmonary fungal infections, combining rigorous clinical observation with the use of novel diagnostic technologies, including machine learning and metagenomic sequencing. His publications in high-impact journals such as The Lancet Infectious Diseases, Microbiology Spectrum, Frontiers in Cellular and Infection Microbiology, and Clinical Microbiology and Infection reflect a deep commitment to advancing evidence-based practices and diagnostic accuracy in the field. Through his groundbreaking studies, Professor Su has introduced innovative diagnostic models that integrate big data analytics with clinical biomarkers, offering more precise and timely identification of IPA and related fungal diseases. Beyond diagnostics, his investigations into host immune responses, interferon signaling, and biomarker development have opened new avenues for prognostic assessment and personalized treatment strategies. His leadership roles as a Chief Physician, Professor, and Doctoral Supervisor at Nanjing University-affiliated hospitals underscore his dual impact as both a clinician and academic mentor. Colleagues and collaborators recognize his unique ability to unite global expertise, as evidenced by his participation in international research consortia addressing fungal infections and severe pneumonia outcomes. His scholarly rigor, coupled with his mentorship of young clinicians and researchers, has significantly enriched the field of respiratory and infectious disease research. While Professor Su’s scientific achievements are substantial, he continues to identify strategic growth areas that align with the evolving challenges of respiratory medicine. Expanding the clinical utility of machine learning-based diagnostic platforms, validating novel biomarkers in diverse patient populations, and enhancing global collaborative networks remain key objectives. Moreover, strengthening translational pathways that connect molecular diagnostics to frontline patient care is an ongoing priority, ensuring that innovations in the laboratory translate into improved clinical outcomes. Looking ahead, Professor Su’s future research aims to deepen the mechanistic understanding of host-pathogen interactions in fungal and viral co-infections, refine AI-driven diagnostic algorithms for pulmonary infections, and integrate multi-omics data into clinical decision-making frameworks. His vision is to establish an internationally recognized precision-medicine model for diagnosing and managing severe respiratory infections, ultimately contributing to reduced mortality, optimized therapeutic strategies, and global health resilience in the era of emerging respiratory pathogens. He has 2677 citations from 128 documents with an h-index of 28.

Profiles: Scopus | ORCID

Publications

1. Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis. (2025). Microbiology Spectrum.

2. Rapid and accurate diagnosis of severe pneumonia: Similarities and differences between severe community-acquired pneumonia and hospital-acquired pneumonia/ventilator-associated pneumonia. (2025). Chinese Journal of Tuberculosis and Respiratory Diseases.

3. Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: A multicenter cohort study. (2025). Microbiology Spectrum.

4. Expert consensus on cancer treatment-related lung injury. (2025). Journal of Thoracic Disease.

5. Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients. (2025). Microbiology Spectrum.

Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award

Dr. Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award 

Professor | UCLA | United States

Dr. Yvonne L. Hernandez-Kapila is a distinguished clinician-scientist, academic leader, and global research contributor recognized for her transformative work in oral biology, periodontology, and cancer biology. As Professor and Associate Dean for Research at the UCLA School of Dentistry and the Felix and Mildred Yip Endowed Chair in Dentistry, her research has significantly advanced understanding of the molecular and cellular mechanisms underlying periodontal disease, oral cancer, and host-microbiome interactions. Her laboratory’s pioneering investigations into the oral-gut-brain axis, bacteriocin therapeutics, and oral virome have shaped new paradigms in microbial pathogenesis, inflammation, and regenerative oral health. A prolific author with more than a hundred peer-reviewed publications in leading journals such as NPJ Biofilms and Microbiomes, Journal of Biological Chemistry, PLOS Pathogens, and Cell Death and Differentiation, Dr. Kapila’s work bridges fundamental discovery with translational innovation. She has served as principal investigator on multiple NIH-funded projects, including major initiatives exploring host–bacterial dynamics and microbiome modulation in oral and systemic disease contexts. Her editorial leadership extends across several international journals and major textbooks, including Periodontology 2000 and Newman and Carranza’s Clinical Periodontology, where she continues to shape scholarly discourse in the field. Dr. Kapila has received numerous prestigious honors recognizing her scientific excellence, mentorship, and contributions to dental research, including awards from the American Dental Association, the American Academy of Periodontology, and the American Association for Dental Research. A dedicated mentor, she has guided over a hundred trainees and junior faculty toward successful academic and research careers worldwide, championing inclusivity, rigorous scientific methodology, and leadership development. Through her interdisciplinary collaborations and global initiatives, Dr. Kapila continues to influence the future of oral health sciences, biomolecular therapeutics, and translational medicine, establishing herself as a leading voice in advancing oral-systemic health research on an international scale. She has 8347 citations from 146 documents with an h-index of 47.

Profiles: Scopus | ORCID

Publications

1. B. lactis HN019 modulates periapical inflammation and enhances cementum repair by increasing CEMP-1 expression in an animal model. (2025). Archives of Oral Biology.

2. The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection. (2025). Virology Journal.

3. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. (2024). NPJ Biofilms and Microbiomes.

4. Biological biomarkers of oral cancer. (2025). [Journal name not specified].

5. Nisin, a probiotic bacteriocin, modulates the inflammatory and microbiome changes in female reproductive organs mediated by polymicrobial periodontal infection. (2024). Microorganisms.

Ahmed Ahmed Olaitan | Global Health and Infectious Disease Burden | Young Scientist Award

Mr. Ahmed Ahmed Olaitan | Global Health and Infectious Disease Burden | Young Scientist Award

PhD Scholar  |  Universiti Sultan Zainal Abidin  |  Nigeria

Mr. Ahmed Ahmed Olaitan is an emerging academic and research scholar whose work bridges sociology, environmental studies, and sustainable development. His professional experience spans research, teaching, and community leadership, with active roles as a Lecturer at the Federal College of Forest Resources Management in Ishiagu, Nigeria, and a Research Fellow at the Forestry Research Institute of Nigeria. His research contributions focus on traditional healthcare practices, indigenous community development, social and environmental sustainability, and the socio-economic dimensions of forestry and agroforestry. He has co-authored multiple peer-reviewed journal articles that explore the intersections of social systems, environmental conservation, and cultural knowledge transmission. His scholarly efforts extend to participation in national and international conferences, where he has presented research on environmental management, indigenous education, and climate change awareness. Ahmed’s research skills encompass qualitative and quantitative methodologies, data analysis using PLS-SEM, SPSS, NVivo, and Excel, and the development of community-based research frameworks that support sustainable livelihoods. His academic excellence has been recognized with honors, including the Graduate on Time Award from Universiti Sultan Zainal Abidin, highlighting his dedication to timely and impactful scholarship. He has also served in leadership capacities such as Treasurer of the International Student Society at Universiti Sultan Zainal Abidin and Principal of Sheikh Ahmad Islamic School in Ilorin, Nigeria, where he promotes education and community empowerment. His work demonstrates a strong commitment to social innovation, research excellence, and practical approaches to achieving sustainable development goals. With a growing academic profile and a collaborative approach to interdisciplinary inquiry, Ahmed continues to contribute significantly to both scholarly research and societal advancement. He has achieved 22 Citations, 9 Documents, 3 h-index .

Profiles:  Google Scholar | ORCID Scopus 

Featured Publications

  1. GO Victory, Oyewole, A. L., & Olaitan, A. A. (2022). Climate-smart agricultural practices at Oyo State, Nigeria. South Asian Journal of Social Review, 1(1), 1–7.
    Citations: 45

  2. Tokede, A. M., Banjo, A. A., Ahmad, A. O., Fatoki, O. A., & Akanni, O. F. (2020). Farmers’ knowledge and attitude towards the adoption of agroforestry practices in Akinyele Local Government Area, Ibadan, Nigeria. Journal of Applied Sciences and Environmental Management, 24(10), 1775–1780.
    Citations: 31

  3. Ibrahim, A., Abdullah, R., Ismail, W. N. A. T., & Olaitan, A. (2023). Strategy formulation to empower indigenous community involvement in cultural ecological tourism of Kuala Tahan National Park. Planning Malaysia, 21, 36–47.
    Citations: 19

  4. Ibrahim, A., Olaitan, A. A., Jazmina, W. N., Simin, M. H. A., & Nizam, M. S. (2023). Capacity building of indigenous youth through skills and career training programs in Malaysia. ISVS e-journal, 10(6), 151–163.
    Citations: 13

  5. Rose, A. O., Morenike, T. A., Ahmad, A. O., & Anne, T. F. A. (2020). Predictor of research productivity among married female research scientists in Oyo State, Nigeria. Journal of Finance and Economics, 8(5), 232–236.
    Citations: 9

Arslan Amin | Infectious Diseases Prevention | Best Researcher Award

Dr. Arslan Amin | Infectious Diseases Prevention | Best Researcher Award

Arslan Amin | Huazhong University of Science and Technology | China

Arslan Amin is a distinguished researcher and communication professional with expertise in media studies, digital communication, health communication, and political communication. His research focuses on the intersections of media, technology, and societal well-being, with a particular emphasis on the impact of social media, media bias, and digital innovations on public perception and behavior. He has published extensively in internationally recognized journals, contributing to critical discourse on AI-driven mental health interventions, racial discrimination and healthcare access, and the influence of deepfake media on political ideology and polarization. His work demonstrates a strong commitment to evidence-based analysis and the application of communication theory to contemporary societal challenges. Beyond publications, Arslan has led and contributed to numerous media projects, including documentaries, news reporting, educational programming, and public awareness campaigns, reflecting his ability to translate research into practical outcomes. He has presented his findings at international academic conferences, engaging with global scholarly communities to advance knowledge in journalism, media studies, and health communication. Arslan’s contributions have been recognized through editorial responsibilities, professional certifications, and leadership roles in collaborative research initiatives, underscoring his dedication to fostering innovation, interdisciplinary collaboration, and ethical communication practices. With expertise in research methodology, media analysis, and digital communication strategies, he continues to shape the field of communication studies while addressing critical societal issues through rigorous, impactful research.

Profiles : Scopus | Google Scholar

Featured Publications

Amin, A., Hong, Y., & Mazhar, B. (2025). The influence of social media deepfake images on political ideology and polarization: The mediating roles of cognitive load and confirmation bias. Journal of Visual Literacy, 44(3), 321–339.

Amin, A., Amin, S., & Ali, S. (2021). GEO News coverage is more biased than ARY News coverage regarding Panama leaks by viewers’ perception. Media and Communication Review, 1(2), 1–18.

Amin, A., Mazhar, B., & Amin, S. (2025). Mental health effects of online gaming: A mediation–moderation model of connectedness and screen time. Mental Health and Digital Technologies.

Amin, A., Hong, Y., & Mazhar, B. (2025). Enhancing AI-driven mental health solutions: The role of social support in Wysa’s effectiveness for stress management and anxiety reduction among international medical students. International Journal of Human–Computer Interaction, 1–16.

Amin, A. (2025). Racial discrimination and its effects on hypertension and healthcare access among African Americans: A critical race theory approach. Journal of African American Studies, 29(2), 253–271.

Wafa Tombari | Vaccines | Best Researcher Award

Assist. Prof. Dr. Wafa Tombari | Vaccines | Best Researcher Award

Assistant Professor | University Hospital of Sahloul | Tunisia

Dr. Wafa Tombari, Ph.D., is an accomplished Assistant Professor and Research Scientist at the University Hospital of Sahloul, Sousse, specializing in infectious diseases with a focus on virology, vaccine development, and antimicrobial resistance. She holds a Doctoral Diploma in Biology from the Faculty of Sciences in Tunisia, a Master of Science in Microbiology, and a Certificate of Complementary Studies in Statistics and Epidemiological Methods from the Faculty of Medicine in Tunisia. With a distinguished academic and research career, Dr. Tombari has served as an Assistant Professor at both the High Institute of Medical Technologies and the University Hospital of Sahloul, where she has successfully led and collaborated on numerous national and international research projects. Her research integrates molecular biology, bioinformatics, and immunoinformatics to develop computational approaches for vaccine design, antiviral therapeutics, and the study of bacterial resistance mechanisms. She has authored several peer-reviewed publications in reputable international journals, including studies on mRNA-based vaccines for rabies virus and molecular characterization of antimicrobial resistance in Staphylococcus species, highlighting her contributions to advancing biomedical innovation. Beyond her research, Dr. Tombari plays an active role in student mentorship, curriculum development, and scientific outreach, fostering collaboration and innovation within the academic community. Her expertise extends to reverse vaccinology, molecular cloning, and phylogenetic analysis, reflecting her multidisciplinary approach to infectious disease research. Dr. Tombari’s scholarly achievements and professional dedication exemplify her commitment to advancing global health through science and education. She has achieved 119 citations, published 10 scientific documents, and holds an h-index of 5, reflecting her academic influence and research excellence.

Profiles: Scopus | Google Scholar

Featured Publications

1. Tombari, W., Nsiri, J., Larbi, I., Guerin, J. L., & Ghram, A. (2011). Genetic evolution of low pathogenicity H9N2 avian influenza viruses in Tunisia: . Acquisition of new mutations. Virology Journal, 8(1), 467.

2. Tombari, W., Paul, M., Bettaieb, J., Larbi, I., Nsiri, J., Elbehi, I., Gribaa, L., & Ghram, A. (2013). Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia. PLoS ONE, 8(1), e53524.

3. Boudaoud, A., Mamache, B., Tombari, W., & Ghram, A. (2016). Virus mutations and their impact on vaccination against infectious bursal disease (Gumboro disease). Revue Scientifique et Technique, 35(3), 875–897.

4. Kallel Sellami, M., Zitouni, M., Tombari, W., Ben Ayed, M., Abida, O., Laadhar, L., et al. (2007). Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. British Journal of Dermatology, 156(3), 591–593.

Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Mr. Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Lecturer | Debre Tabor University | Ethiopia 

Dr. Chalachew Yenew Dinku is an accomplished Lecturer and Researcher at Debre Tabor University, Ethiopia, specializing in Environmental and Public Health, with a research focus on environmental and occupational exposure, antimicrobial resistance (AMR), infection prevention and control, One Health, and public health emergency management. He holds a Master of Science in Environmental Health Sciences from Jimma University, where his thesis on AMR contamination pathways received an international research grant and resulted in multiple peer-reviewed publications. He earned his Bachelor of Science in Environmental and Occupational Health and Safety from the University of Gondar, where his undergraduate research on hospital indoor bacterial contamination gained national recognition. With over nine years of professional experience, Dr. Yenew has held key academic and public health roles, including as a Public Health Emergency Surveillance Officer with the Ohio State University Global One Health Initiative and as a Public Health Officer under the Amhara Health Bureau, where he led health education, surveillance, and community health initiatives. At Debre Tabor University, he has served as a member of research committees, supervised postgraduate students, and secured major institutional research grants such as “Addressing Antimicrobial Resistance through a One Health Approach” and “Scabies Screening and Prevention”. Dr. Yenew has authored or co-authored over 55 scientific papers, with 35 published in reputable international journals, 15 as first or corresponding author, and several under review. His extensive editorial contributions include serving as an editor for BMC Public Health, a reviewer for multiple high-impact journals, and a conference presenter at more than 20 national and international scientific events. His research integrates advanced statistical and molecular approaches to tackle pressing public health challenges, bridging academia, policy, and practice. With 355 citations, 47 indexed documents, and an h-index of 9, Dr. Chalachew Yenew exemplifies scholarly excellence, leadership, and commitment to advancing sustainable, evidence-based One Health solutions globally.

Profiles: Scopus | ORCID

Featured Publications

1. Anteneh, R. M., Gashu, Z. E., Baffa, L. D., Bitew, D. A., Yenew, C., Demissie, K. A., Terefe, B., Jejaw, M., Zegeye, A. F., Tiruneh, M. G., et al. (2025). Decomposing socioeconomic and educational inequalities in infant mortality in Sub-Saharan Africa. BMC Public Health, 25(12), 1–12.

2. Mehari, M. G., Yeshiwas, A. G., Esubalew, D., Azmeraw, Y., Delie, A. M., Limenh, L. W., Worku, N. K., Hailu, M., Melese, M., Abie, A., et al. (2025). Dominance of antimicrobial resistant bacteria and risk factors of bacteriuria infection among pregnant women in East Africa. Journal of Health, Population and Nutrition, 25(12), 1–12.

3. Temesgen, A., Anteneh, R. M., Yeshiwas, A. G., Bayeh, G. M., Yenew, C., Ejigu, A. G., Gebeyehu, A. A., Tsega, T. D., Ahmed, A. F., Yemata, G. A., et al. (2025). Systematic review and meta-analysis on gaps in household waste management practices in urban Ethiopia for supporting the TSEDU Ethiopia initiative. Discover Sustainability, 25(12), 1–12.

4. Tsega, T. D., Tsega, S. S., Gebeyehu, A. A., Yemata, G. A., Anteneh, R. M., Yeshiwas, A. G., Yirdaw, G., Yenew, C., Enawgaw, A. S., Ejigu, A. G., et al. (2025). Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa. BMC Infectious Diseases, 25(12), 1–12.

Achilleas Livieratos | Infectious Diseases Vaccines | Best Researcher Award

Dr. Achilleas Livieratos | Infectious Diseases Vaccines | Best Researcher Award

Medical Researcher | Stanford University | Greece

Dr. Achilleas Livieratos, PhD, MRSB, is a distinguished biomedical researcher whose work bridges immunology, infectious diseases, circadian biology, and artificial intelligence applications in health sciences. His research integrates advanced computational methods, including machine learning and multi-agent transformer frameworks, to enhance evidence generation, vaccine immunology, and drug safety analytics. He has published extensively in leading journals such as Vaccines, Pathogens, Viruses, eClinicalMedicine, and Value in Health, contributing to global understanding of immune response dynamics, precision medicine, and outcomes research. Notably, his development of MetaMind, an AI-driven framework for automated network meta-analyses, and his studies on circadian influences on influenza vaccine immunity have been recognized as groundbreaking contributions. His investigations into immune durability across respiratory viruses, including RSV, SARS-CoV-2, and influenza, as well as his exploration of alternative therapies for long COVID, have significantly advanced clinical and translational knowledge. As a lead collaborator with Stanford University and the University of California, San Francisco, Dr. Livieratos has directed international research initiatives on infectious disease modeling, biomarker discovery, and the application of AI in health outcomes research. His earlier work at the University of Oxford produced landmark discoveries in neurogenetics and circadian disruption, underpinning his multidisciplinary expertise. Through leadership in European Pharma and AI consortia, he continues to drive innovation in predictive health analytics and precision therapeutics, demonstrating an exceptional fusion of biomedical insight, computational innovation, and translational research impact.

Profiles : Google Scholar | Scopus

Featured Publication

Oliver, P. L., Sobczyk, M. V., Maywood, E. S., Edwards, B., Lee, S., Livieratos, A., et al. (2012). Disrupted circadian rhythms in a mouse model of schizophrenia. Current Biology, 22(4), 314–319.

Taylor, T. N., Potgieter, D., Anwar, S., Senior, S. L., Janezic, S., Threlfell, S., Ryan, B., et al. (2014). Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease, 62, 193–207.

Wobst, H. J., Denk, F., Oliver, P. L., Livieratos, A., Taylor, T. N., Knudsen, M. H., et al. (2017). Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy. Scientific Reports, 7(1), 43198.

Livieratos, A., Gogos, C., & Akinosoglou, K. (2024). Impact of prior COVID-19 immunization and/or prior infection on immune responses and clinical outcomes. Viruses, 16(5), 685.

Livieratos, A., Gogos, C., & Akinosoglou, K. (2024). Beyond antivirals: Alternative therapies for long COVID. Viruses, 16(11), 1795.